Skip to content

European CURE AF study, Concomitant Uitlization of Radiofrequency Energy for Atrail Fibrillation

European CURE AF study, Concomitant Uitlization of Radiofrequency Energy for Atrail Fibrillation - European CURE AF study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33162
Enrollment
20
Registered
2009-11-06
Start date
2009-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart rhythm disease irregular heart rhythm

Interventions

Radio frequency ablation of the right and left atrium during open heart surgery

Sponsors

Medtronic
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1 Documented history of AF 2 Concomitant indication (other than AF) for open-heart surgery 3 Able to take the anticoagulant warfarin 4 Greater than or equal to 18 years of age; 5 Able and willing to comply with study requirements by signing a Patient Informed Consent form.

Exclusion criteria

Exclusion criteria: 1 NYHA functional class = IV, 2 Left ventricular ejection fraction 7.0 cm, 4 Need for emergent cardiac surgery (i.e. cardiogenic shock) or redo open heart surgery, 5 Previous atrial ablation, AV-nodal ablation, or surgical Maze procedure, 6 Pregnancy or desire to be pregnant within 12-months of the study treatment.

Design outcomes

Primary

MeasureTime frame
Occurrence of AF after ablation

Secondary

MeasureTime frame
Use of antiarrhythmic medication and antithromboembolic mediaction after ablation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)